BORN TO DISCOVER

30+ YEAR HISTORY

We are the only biopharmaceutical company led by physician-scientists for our entire, 30+ year history. From our first days, science was and remains our central guiding principle. We continue to invest in groundbreaking technologies and research, and employ strategies that enable our scientists to consistently explore new paths.

Read a profile of Regeneron Scientist Aynur Hermann Read a profile of Regeneron Scientist Xiaobin Xu

REGENERON LABS

We are focused on addressing a broad range of serious medical conditions including ophthalmology, cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. Our industry-leading research and development engine enables us to develop all potential drug candidates from within our own labs.

Our science

DIVERSE PIPELINE

Our strategy is to follow the science, rather than limiting our innovations to any one therapeutic area. We are focused on solving the human body's most complex mysteries — from ophthalmology to cancer to inflammation to pain to cardiovascular disease. This includes 20 product candidates in clinical development across multiple therapeutic areas.

Our pipeline

TECHNOLOGY THAT BREAKS BOTTLENECKS

Our core capabilities for target discovery and validation are enabled by a series of Regeneron-invented technologies that accelerate, improve and disrupt the traditional drug discovery and development process. Collectively, these technologies represent some of the most valuable biotechnologies ever created, and aid our efforts to continuously accelerate the average timeline from discovery to drug approval.

See how we're raising the bar
  • VelociGene® biotechnology enables rapid, automated and high-scale manipulation of mouse DNA, with almost no limitations on the size and sophistication of modifications.
  • VelociMouse® is a breakthrough technology that enables the immediate generation of genetically altered mice directly from modified embryonic stem cells, thereby avoiding the need to breed multiple generations.
  • VelocImmune® is our unique technology for producing fully human monoclonal antibodies.
  • VelociMab® is a group of technologies that allow us to move with unprecedented speed from identification of a therapeutic antibody into clinical studies.
  • VelociT™ is our unique technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens.
  • VelociHum™ biotechnology is our immunodeficient mouse platform that can be used to accurately test human therapeutics against human immune cells and to study human tumor models.
  • VelociGene® biotechnology enables rapid, automated and high-scale manipulation of mouse DNA, with almost no limitations on the size and sophistication of modifications.
  • VelocImmune® is our unique technology for producing fully human monoclonal antibodies.
  • VelociT™ is our unique technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens.
  • VelociMouse® is a breakthrough technology that enables the immediate generation of genetically altered mice directly from modified embryonic stem cells, thereby avoiding the need to breed multiple generations.
  • VelociMab® is a group of technologies that allow us to move with unprecedented speed from identification of a therapeutic antibody into clinical studies.
  • VelociHum™ biotechnology is our immunodeficient mouse platform that can be used to accurately test human therapeutics against human immune cells and to study human tumor models.

FIND OUT WHY OUR SCIENTISTS DO WHAT THEY DO

Our colleagues have backgrounds as diverse as the problems we’re working to solve. Here are just a few of their stories.

Meet Alyson

The musical theater stage and the Regeneron lab have more in common than you might think. Both inspire a group of people to work together toward a common goal. Every day, Regeneron scientist Alyson works with her ophthalmology team to help answer the important questions about retinal eye diseases to ensure patients are receiving the most effective treatments.

Meet Dinko

Dinko’s curiosity about the natural world inspired him to pursue a career in science. Now he uses imaging technology to innovate and positively impact the lives of patients with rare diseases like Fibrodysplasia Ossificans Progressiva (FOP).

Meet George

Our President and Chief Scientist, George Yancopoulos, followed in the footsteps of his grandfather to pursue science. Watch to find out how he works every day to invent and discover the next new medicine that makes a difference in patients’ lives.

Meet Jean

Biology is a complex puzzle, and scientists, like Jean, work to solve these puzzles by gathering and interpreting results that inform the creation of life-changing medicines. Jean shares how her passion for designing dresses led her to a career designing experiments at Regeneron.

Meet Petra

When she was young, Petra wanted to be a veterinarian like her dad. But then she enjoyed working with people. Now, she is a Regeneron scientist finding ways to outsmart cancer with immuno-oncology.

Meet Vishal

Regeneron scientist Vishal followed his curiosity to a career studying antibodies to help bring medicine to people living with disease.

Meet Wilson

Clinical trials are crucial to determine if compounds are useful, effective and safe. Wilson oversees this process at Regeneron to ensure our clinical plans are executed in high quality.

Meet Zachary

Zack’s curiosity about the science behind our life-changing medicines led him to a career on our Industrial Operations and Product Supply (IOPS) team. His work is the scientific backbone of our product supply facility.

REGENERON
GENETICS CENTER

We have built one of the world's most comprehensive genotype-phenotype databases, enabling deeper understanding of the genetic factors that cause or influence a range of human diseases.

The Regeneron Genetics Center

PUBLICATIONS

We encourage our pioneering scientists to regularly publish their research in leading scientific journals, including more than 100 in 2018 to date.

Recent publications
Regeneron Science Talent Search: A program of society for science & the public

INNOVATIVE LEADERSHIP

We consistently demonstrate our commitment to scientific excellence by including multiple Nobel Laureates and five members of the National Academy of Sciences in our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard. We are also the proud sponsors of the Regeneron Science Talent Search.

Our leadership

UNITED IN DISCOVERY

Along with our distinguished collaborators, we are uncovering cutting-edge scientific advances. Partner with our researchers and help turn science into life-changing medicine.

Our collaborations